An Oklahoma Medical Research Foundation project to research a treatment for Glioblastoma, a type of brain tumour, has secured $1m in funding, with support from not for profit corporation i2E.

The Glioblastoma Project of the Oklahoma Medical Research Foundation has raised $1m, with half the money provided by the Oklahoma Medical Research Foundation.

The foundation was joined by US-based non-profit corporation i2E, which invested $500,000 through the Oklahoma Seed Capital Fund, a state-backed fund.

The Glioblastoma Project is exploring a treatment for Glioblastoma, a type of brain tumour.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?